ABUS:NASDAQ
Arbutus Biopharma Corp
$5.01
arrow_downward
-1.18%(-0.060) 1D
$5.00
arrow_downward
-0.20% (-0.010)bedtimeAfter hours
Closed: Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABUS...
Open
$5.04
High
$5.06
Low
$4.98
Mkt. cap
992.51M
Avg. vol.
4.04M
Volume
6.46M
P/E ratio
6.40
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.62
Shares outstanding
198.11M
No. of employees
19
Open
$5.04
High
$5.06
Low
$4.98
Mkt. cap
992.51M
Avg. vol.
4.04M
Volume
6.46M
P/E ratio
6.40
52-wk high
$5.45
52-wk low
$3.50
EPS
$0.78
Beta
0.62
Shares outstanding
198.11M
No. of employees
19
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
Arbutus Biopharma (ABUS) Edges Higher to $4.38 as Shares Trade Within Defined Range - IV Percentile
CarePlus VietNam
·
2 months ago
ABUS Q1 2026 Earnings: EPS Miss Amidst Ongoing Development Progress - Return On Capital
Profile
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
About Arbutus Biopharma Corp
CEOWilliam H. Collier
Employees19
Founded2007
HeadquartersWarminster Township, Pennsylvania, United States
SectorBiotechnology
Websitearbutusbio.com